Mobile

An open label, two period crossover study to explore the safety, pharmacokinetics and pharmacodynamics of PHA-794428 after single subcutaneous injections in adult male patients with growth hormone def...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-001658-25

An open label, two period crossover study to explore the safety, pharmacokinetics and pharmacodynamics of PHA-794428 after single subcutaneous injections in adult male patients with growth hormone deficiency

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To explore the pharmacokinetics and pharmacodynamics of PHA-794428 after single subcutaneous injections in AGHD patients in order to support the development of a PK/PD model in this patient population. To explore the safety, tolerance and humoral response of PHA-794428 after single subcutaneous injections in AGHD patients.

Critère d'inclusion

  • AGHD Adult Growth Hormone Deficiency

Liens